{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T07:53:55Z","timestamp":1764921235328,"version":"3.46.0"},"reference-count":39,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T00:00:00Z","timestamp":1764892800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell Dev. Biol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>\n                      Hepatocellular carcinoma (HCC) is the ultimate result of long-term chronic hepatitis B. Molecular interactions among parenchymal, non-parenchymal, and immune cells in the liver tumor microenvironment (TME) influence the progression of the disease by sharing molecules such as protein, nucleic acids (DNA, coding and non-coding RNAs), lipids, and others through extracellular vesicles (EVs). This study has examined the influence of Hepatitis B virus (HBV) on the enrichment of proteins in the HCC cell-derived EVs and\n                      <jats:italic>vice versa<\/jats:italic>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>EVs were isolated from conditioned media of stable HBV-containing HepG2.2.15 and HepG2-vector cells using kit and the quality was verified by Nano-particle tracking analysis (NTA) and immunoblotting with EV-specific antibody. Proteome analysis was performed in triplicate with the isolated EV-protein content using label-free LC-MS\/MS technology and validated using HBV infected Huh7 and HepG2 cells. Various bioinformatics tools, transfection with Full-length (FL) HBV, anti-sense-oligo (ASO) treatment, immunoblotting, qRT-PCR, chromatin-immunoprecipitation (ChIP), cell proliferation, migration and spheroid formation assays were performed as required. Student\u2019s t-test was performed for statistical analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Proteome data analysis showed that HBV triggered accumulation of 3.4 times more proteins in the EVs-derived from HepG2.2.15 (2,293 proteins) compared to HepG2-vector cells (677 proteins). Differential expression (DE) analysis and subsequent validation with proteomics data of HBV-HCC liver tissue samples revealed enrichment of 103 commonly DE proteins in the EVs of HepG2.2.15 cells. These proteins mostly participated in DNA repair, RNA metabolism, and Golgi trafficking pathways, and these proteins were also overexpressed within cells in presence of HBV. Furthermore, protein-protein network and Hub gene analysis identified 10 key proteins that can interact with other proteins in the network. One of these hub proteins, programmed cell death protein 11 (PDCD11), has been identified as a carrier of HBV-RNA\/DNA to the EVs. Depletion of PDCD11 limited the accumulation of HBV-RNAs (pre-genomic RNA, HBx, HBc, HBs mRNAs) and intact virions into the EVs. The FL-HBV genome was detected within EV-enriched virus core particles, which have the potential to infect na\u00efve hepatocytes. Next, integrated transcription factor (TF)-mRNA-miRNA network analysis and validation revealed that TFDP1 transcriptionally upregulated PDCD11, along with other hub proteins, while miR-1-3p has been characterized to suppress their expressions. The binding of TFDP1 to the promoters of the hub genes was further confirmed by ChIP followed by qRT-PCR. Finally, depletion of TFDP1 using ASO and restoration of miR-1-3p in Huh7 cells restricted proliferation, migration, epithelial to mesenchymal transition, and stemness traits in HBV-infected HCC cells.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Proteins enriched in the EVs-derived from HCC cells in presence of HBV may be further investigated to identify novel therapeutic targets within the TME of HBV-HCC. Our findings demonstrated the therapeutic potential of TFDP1-ASO and miR-1-3p, which could lead to new approaches in HBV-HCC treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcell.2025.1643823","type":"journal-article","created":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T07:52:00Z","timestamp":1764921120000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Proteome profiling of extracellular vesicles-derived from hepatitis B virus-infected hepatocellular carcinoma cell lines identifies PDCD11 as a carrier of viral RNAs"],"prefix":"10.3389","volume":"13","author":[{"given":"Indrashish","family":"Dey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anusmriti","family":"Das","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Subhas","family":"Das","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soham","family":"Saha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abhijit","family":"Chowdhury","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simanti","family":"Datta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soma","family":"Banerjee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,12,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.pharmthera.2017.02.020","article-title":"Exosomes: therapy delivery tools and biomarkers of diseases","volume":"174","author":"Barile","year":"2017","journal-title":"PharmacolTher"},{"key":"B2","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/s41568-019-0196-7","article-title":"Targeting transcription factors in cancer - from undruggable to reality","volume":"19","author":"Bushweller","year":"2019","journal-title":"Nat. Rev. Cancer"},{"key":"B3","doi-asserted-by":"publisher","first-page":"8011","DOI":"10.3390\/ijms22158011","article-title":"Role of immune cells in patients with hepatitis B virus-related hepatocellular carcinoma","volume":"27","author":"Cho","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B4","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/s41392-020-00261-0","article-title":"Exosomes: key players in cancer and potential therapeutic strategy","volume":"5","author":"Dai","year":"2020","journal-title":"Signal Transduct. Target Ther."},{"key":"B5","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1186\/s12967-023-04649-8","article-title":"The important role of miR-1-3p in cancers","volume":"21","author":"Dai","year":"2023","journal-title":"J. Transl. Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1093\/carcin\/bgx145","article-title":"Oncogenic potential of hepatitis B virus subgenotype D1 surpasses D3: significance in the development of hepatocellular carcinoma","volume":"39","author":"Datta","year":"2018","journal-title":"Carcinogenesis"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1149551","DOI":"10.3389\/fonc.2023.1149551","article-title":"Pancreatic cancer and exosomes: role in progression, diagnosis, monitoring, and treatment","volume":"13","author":"Fang","year":"2023","journal-title":"Front. Oncol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"2934","DOI":"10.1002\/ijc.33111","article-title":"The exosome encapsulated microRNAs as circulating diagnostic marker for hepatocellular carcinoma with low alpha-fetoprotein","volume":"147","author":"Ghosh","year":"2020","journal-title":"Int. J. Cancer"},{"key":"B9","doi-asserted-by":"publisher","first-page":"4142","DOI":"10.7150\/jca.30493","article-title":"HBV integration-mediated cell apoptosis in HepG2.2.15","volume":"10","author":"Hu","year":"2019","journal-title":"J. Cancer"},{"key":"B10","doi-asserted-by":"publisher","first-page":"157","DOI":"10.2174\/1570159x14666160825160421","article-title":"Exosomes: the messengers of health and disease","volume":"15","author":"Isola","year":"2017","journal-title":"CurrNeuropharmacol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"S144","DOI":"10.1074\/mcp.M116.063503","article-title":"Label-free proteomic analysis of exosomes derived from inducible hepatitis B virus-replicating HepAD38 cell line","volume":"16","author":"Jia","year":"2017","journal-title":"Mol. Cell Proteomics"},{"key":"B12","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/s41586-019-0987-8","article-title":"Proteomics identifies new therapeutic targets of early-stage hepatocellular carcinoma","volume":"567","author":"Jiang","year":"2019","journal-title":"Nature"},{"key":"B13","doi-asserted-by":"publisher","first-page":"143543","DOI":"10.1016\/j.ijbiomac.2025.143543","article-title":"TFDP1 drives triple-negative breast cancer development through senescence suppression and serves as a therapeutic target for topotecan","volume":"310","author":"Ju","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"12449","DOI":"10.1074\/jbc.RA120.014317","article-title":"Extracellular vesicles secreted by HBV-infected cells modulate HBV persistence in hydrodynamic HBV transfection mouse model","volume":"295","author":"Kakizaki","year":"2020","journal-title":"J. Biol. Chem."},{"key":"B15","doi-asserted-by":"publisher","first-page":"8055","DOI":"10.1038\/s41598-018-26414-4","article-title":"Distinctiveness in virological features and pathogenic potentials of subgenotypes D1, D2, D3 and D5 of Hepatitis B virus","volume":"8","author":"Khatun","year":"2018","journal-title":"Sci. Rep."},{"key":"B16","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.2147\/JHC.S436962","article-title":"Tumor microenvironment composition and related therapy in hepatocellular carcinoma","volume":"10","author":"Li","year":"2023","journal-title":"J. Hepatocell. Carcinoma"},{"key":"B17","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s12943-019-0991-5","article-title":"Exosomes: composition, biogenesis, and mechanisms in cancer metastasis and drug resistance","volume":"18","author":"Mashouri","year":"2019","journal-title":"Mol. Cancer"},{"key":"B18","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1080\/13651820410024058","article-title":"Staging systems in hepatocellular carcinoma","volume":"7","author":"Pons","year":"2005","journal-title":"HPB Oxf."},{"key":"B19","doi-asserted-by":"publisher","first-page":"500","DOI":"10.3390\/ijms23010500","article-title":"Hepatocellular carcinoma in chronic viral hepatitis: where do we stand?","volume":"23","author":"Russo","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"B20","doi-asserted-by":"publisher","first-page":"6085","DOI":"10.3390\/cimb45070384","article-title":"Exosome analysis in prostate cancer: how they can improve biomarkers' performance","volume":"45","author":"Salciccia","year":"2023","journal-title":"Curr. Issues Mol. Biol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.jcmgh.2016.10.003","article-title":"Transmission of HBV DNA mediated by ceramide-triggered extracellular vesicles","volume":"3","author":"Sanada","year":"2016","journal-title":"Cell Mol. Gastroenterol. Hepatol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1016\/j.jtho.2016.05.034","article-title":"Exosomal proteins as diagnostic biomarkers in lung cancer","volume":"11","author":"Sandfeld-Paulsen","year":"2016","journal-title":"J. Thorac. Oncol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/s41575-021-00438-0","article-title":"Advances in immunotherapy for hepatocellular carcinoma","volume":"18","author":"Sangro","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"3778","DOI":"10.3390\/ijms23073778","article-title":"Tumor microenvironment of hepatocellular carcinoma: challenges and opportunities for new treatment options","volume":"23","author":"Sas","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"B25","doi-asserted-by":"publisher","first-page":"e0195969","DOI":"10.1371\/journal.pone.0195969","article-title":"Identification of RNA-binding proteins in exosomes capable of interacting with different types of RNA: RBP-facilitated transport of RNAs into exosomes","volume":"13","author":"Statello","year":"2018","journal-title":"PLoS One"},{"key":"B26","doi-asserted-by":"publisher","first-page":"105","DOI":"10.2174\/187152609787847677","article-title":"Drug targets in hepatitis B virus infection","volume":"9","author":"Stein","year":"2009","journal-title":"Infect. Disord. Drug Targets"},{"key":"B27","doi-asserted-by":"publisher","first-page":"107240","DOI":"10.1016\/j.bspc.2024.107240","article-title":"Multi-omics uncovers the potential functions of transcription factor Dp-1 in human digestive cancers","volume":"101","author":"Sung","year":"2025","journal-title":"Biomed. Signal Process. Control"},{"key":"B28","doi-asserted-by":"publisher","first-page":"e19296","DOI":"10.1016\/j.heliyon.2023.e19296","article-title":"Tumor cell-derived exosomes regulate macrophage polarization: emerging directions in the study of tumor genesis and development","volume":"9","author":"Tan","year":"2023","journal-title":"Heliyon"},{"key":"B29","doi-asserted-by":"publisher","first-page":"6673","DOI":"10.3390\/molecules27196673","article-title":"Recent advances in detection for breast-cancer-derived exosomes","volume":"27","author":"Tang","year":"2022","journal-title":"Molecules"},{"key":"B30","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/nrm.2017.125","article-title":"Shedding light on the cell biology of extracellular vesicles","volume":"19","author":"Van Niel","year":"2018","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.jare.2023.11.029","article-title":"Exploring the roles and molecular mechanisms of RNA binding proteins in the sorting of noncoding RNAs into EVs during tumor progression","volume":"65","author":"Wang","year":"2023","journal-title":"J. Adv. Res."},{"key":"B32","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1620\/tjem.252.309","article-title":"Exosomes in hepatitis B virus transmission and related immune response","volume":"252","author":"Wang","year":"2020","journal-title":"Tohoku J. Exp. Med."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1038\/s41467-021-21850-9","article-title":"Hepatitis B virus cccDNA is formed through distinct repair processes of each strand","volume":"12","author":"Wei","year":"2021","journal-title":"Nat. Commun"},{"key":"B34","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/s41578-020-00277-6","article-title":"Extracellular vesicles versus synthetic nanoparticles for drug delivery","volume":"6","author":"Witwer","year":"2021","journal-title":"Nat. Rev. Mater"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.7150\/ijms.52768","article-title":"Subpopulations of exosomes purified via different exosomal markers carry different microRNA contents","volume":"18","author":"Wu","year":"2021","journal-title":"Int. J. Med. Sci."},{"key":"B36","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.jcmgh.2022.09.012","article-title":"Presence of intact hepatitis B virions in exosomes","volume":"15","author":"Wu","year":"2023","journal-title":"Cell Mol. Gastroenterol. Hepatol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1186\/s12935-022-02594-y","article-title":"Exosomal microRNAs shuttling between tumor cells and macrophages: cellular interactions and novel therapeutic strategies","volume":"22","author":"Xu","year":"2022","journal-title":"Cancer Cell Int."},{"key":"B38","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.2147\/OTT.S197326","article-title":"MiR-1-3p suppresses proliferation of hepatocellular carcinoma through targeting SOX9","volume":"12","author":"Zhang","year":"2019","journal-title":"OncoTargets Ther."},{"key":"B39","doi-asserted-by":"publisher","first-page":"3816","DOI":"10.1111\/jcmm.13654","article-title":"miR-21 promotes cardiac fibroblast-to-myofibroblast transformation and myocardial fibrosis by targeting Jagged1","volume":"22","author":"Zhou","year":"2018","journal-title":"J. Cell Mol. Med."}],"container-title":["Frontiers in Cell and Developmental Biology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2025.1643823\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T07:52:01Z","timestamp":1764921121000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2025.1643823\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,5]]},"references-count":39,"alternative-id":["10.3389\/fcell.2025.1643823"],"URL":"https:\/\/doi.org\/10.3389\/fcell.2025.1643823","relation":{},"ISSN":["2296-634X"],"issn-type":[{"value":"2296-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,5]]},"article-number":"1643823"}}